Cargando…
Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo
Access lag to innovative therapies in Asian populations continues to present a challenge to global health. Recent progressive changes in the global regulatory landscape, including newer guidelines, are enabling simultaneous global drug development and near‐simultaneous global drug registration. The...
Autores principales: | Venkatakrishnan, Karthik, Gupta, Neeraj, Smith, Patrick F., Lin, Tiffany, Lineberry, Neil, Ishida, Tatiana, Wang, Lin, Rogge, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083990/ https://www.ncbi.nlm.nih.gov/pubmed/35342942 http://dx.doi.org/10.1002/cpt.2591 |
Ejemplares similares
-
Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial
por: Zhou, Xiaofei, et al.
Publicado: (2021) -
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies
por: Pressly, Michelle A., et al.
Publicado: (2023) -
From clinical data management to clinical data science: Time for a new educational model
por: Ittenbach, Richard F.
Publicado: (2023) -
Agent‐Based Modeling in Systems Pharmacology
por: Cosgrove, J, et al.
Publicado: (2015) -
Logic Modeling in Quantitative Systems Pharmacology
por: Traynard, Pauline, et al.
Publicado: (2017)